Evidence map›Paper›PMID 40006057›Full record

ReviewPharmaceuticals (Basel, Switzerland)2025

Cellular Senescence in Health, Disease, and Lens Aging.

Ying Qin, Haoxin Liu, Hongli Wu

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Cellular senescence and aging: molecular mechanisms and convergent pathways.Cellular and molecular life sciences : CMLS · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ying QinPharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Haoxin LiuPharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.ORCID 0009-0005-5313-3143
Hongli WuPharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.

Funding

Understanding glaucoma risk and assessment of precision therapies: A study of mitochondria and oxidative stress in human trabecular meshworkR01EY034529 · NEI · WASHINGTON UNIVERSITY · PI CARLA J SIEGFRIED · 2023 to 2026
$2.2M
Targeting oxidative stress in neurodegeneration using pyridol-derived small moleculesR15GM123463 · NIGMS · TEXAS CHRISTIAN UNIVERSITY · PI AKKARAJU, GIRIDHAR, CHUMLEY, MICHAEL J · 2018 to 2025
$1.2M
Mechanistic Insights and Therapeutic Potential of the Glutaredoxin (Grx) System in the LensR21EY033941 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI WU, HONGLI · 2023 to 2024
$409k
NEI NIH HHS R01 EY034529NEI NIH HHS R21 EY033941NIGMS NIH HHS R15 GM123463NIH HHS R01EY034529NIH HHS R15GM123463-02NIH HHS R21EY033941
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cataractogenesiscellular senescencelens epithelial cellsoxidative stresssenescence-associated secretory phenotypesenotherapeutics

Identifiers

PMID40006057
PMCPMC11859104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.